These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 30344987

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.
    Kidney Int; 2016 Mar; 89(3):701-11. PubMed ID: 26880462
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.
    Ebrahem R, Kadhem S, Truong Q.
    Cureus; 2017 Mar 23; 9(3):e1111. PubMed ID: 28439485
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab.
    Palma LMP, Eick RG, Dantas GC, Tino MKDS, de Holanda MI, Brazilian Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome Study Group (aHUS Brazil).
    Clin Kidney J; 2021 Apr 23; 14(4):1126-1135. PubMed ID: 33841858
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S, Pradhan M, Meyers KE, Le Palma K, Laskin BL.
    Clin Nephrol; 2015 Sep 23; 84(3):181-5. PubMed ID: 25816809
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.
    Greenwood GT.
    Int Med Case Rep J; 2015 Sep 23; 8():235-9. PubMed ID: 26508891
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A Case Report of Atypical Hemolytic Uremic Syndrome in a Two-Month-Old Infant With a Negative Reported Genetic Profile and Five-Year Follow-Up on Eculizumab.
    Shah S, Sweis L.
    Cureus; 2020 Sep 11; 12(9):e10392. PubMed ID: 32944483
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.